Document Detail


Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.
MedLine Citation:
PMID:  21048181     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Tomislav Smoljanovic; Franjo Siric; Ivan Bojanic
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  The Journal of bone and joint surgery. American volume     Volume:  92     ISSN:  1535-1386     ISO Abbreviation:  J Bone Joint Surg Am     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-04     Completed Date:  2010-12-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0014030     Medline TA:  J Bone Joint Surg Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2614-5; author reply 2615-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthrodesis / adverse effects*,  instrumentation,  methods*
Bone Morphogenetic Proteins / therapeutic use*
Ejaculation
Gelatin Sponge, Absorbable
Genital Diseases, Male / etiology*
Humans
Lumbar Vertebrae / surgery*
Male
Postoperative Complications / etiology*
Recombinant Proteins / therapeutic use*
Spondylolisthesis / surgery
Transforming Growth Factor beta / therapeutic use
Treatment Outcome
United States
United States Food and Drug Administration
Chemical
Reg. No./Substance:
0/Bone Morphogenetic Proteins; 0/Recombinant Proteins; 0/Transforming Growth Factor beta
Comments/Corrections
Comment On:
J Bone Joint Surg Am. 2009 May;91(5):1181-9   [PMID:  19411467 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Novel approaches for the management of tendinopathy.
Next Document:  Brace wear control of curve progression in adolescent idiopathic scoliosis.